Treatment of Unexplained Infertility

Home » fertilPEDIA » Treatment of Unexplained Infertility

By



Attention: You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

This content is WordProof timestamped

This image has an empty alt attribute; its file name is Treatment-of-Unexplained-Infertility.webp

Main article: Unexplained Infertility Overview

Updated: 28-August-2024

Treatment of Unexplained Infertility

The six most common treatment options for couples with unexplained infertility are:

  • Lifestyle
  • Medication
  • Expectant Management
  • IUI
  • IVF
  • Surgery

Lifestyle

Experts recommend addressing any lifestyle factors which can influence fertility.

For women with unexplained infertility this includes factors causing stress, high leptin levels, iodine deficiency or hyperhomocysteinemia. Low BMI will also impact a women’s fertility during natural or assisted conception cycles.1 While obese women may be recommended to lose weight to decrease the risk of pregnancy complications (i.e. preeclampsia).2

For men trying to conceive this includes obesity (i.e. oxidative stress), poor sleep quality (including obstructive sleep apnoea) or diet (PUFA), low vitamin D, smoking and alcohol.3,4,5,6,7,8,9

References

  1. Zheng J, et al. (2022). Low BMI is associated with poor IUI outcomes: a retrospective study in 13,745 cycles. https://link.springer.com/article/10.1007/s10815-022-02658-y ↩︎
  2. Wild R A, et al. (2022). Immediate weight loss before ovarian stimulation with intrauterine insemination is associated with a lower risk of preeclampsia in women with obesity and unexplained infertility. https://www.fertstertreports.org/article/S2666-3341(22)00064-2/fulltext ↩︎
  3. Fariello R M, et al. (2012). Association between obesity and alteration of sperm DNA integrity and mitochondrial activity. https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2011.10813.x ↩︎
  4. Tunc O, et al. (2010). Impact of body mass index on seminal oxidative stress. https://onlinelibrary.wiley.com/doi/10.1111/j.1439-0272.2009.01032.x ↩︎
  5. Palnitkar G, et al. (2018). Linking sleep disturbance to idiopathic male infertility. https://www.sciencedirect.com/science/article/abs/pii/S1087079217301557 ↩︎
  6. Jensen T K, et al. (2013). Association of Sleep Disturbances With Reduced Semen Quality: A Cross-sectional Study Among 953 Healthy Young Danish Men. https://academic.oup.com/aje/article/177/10/1027/101677 ↩︎
  7. Gavrizi S Z, et al. (2023). Sperm very long-chain polyunsaturated fatty acids: relation to semen parameters and live birth outcome in a multicenter trial. https://www.fertstert.org/article/S0015-0282(23)00058-4/fulltext ↩︎
  8. Güngör K, et al. (2022). Relationship between serum vitamin D levels semen parameters and sperm DNA damage in men with unexplained infertility. https://www.europeanreview.org/article/27875 ↩︎
  9. Aboulmaouahib S, et al. (2018). Impact of alcohol and cigarette smoking consumption in male fertility potential: Looks at lipid peroxidation, enzymatic antioxidant activities and sperm DNA damage. https://onlinelibrary.wiley.com/doi/10.1111/and.12926 ↩︎
  10. Cicinelli E, et al. (2017). Chronic endometritis in patients with unexplained infertility: Prevalence and effects of antibiotic treatment on spontaneous conception. https://onlinelibrary.wiley.com/doi/10.1111/aji.12782 ↩︎
  11. Moradan S and Ghorbani R, (2009). Dexamethasone in unexplained infertility. https://pubmed.ncbi.nlm.nih.gov/19668883/ ↩︎
  12. Amin-Florin E K and Florin S, (2022). Improvement of fertility outcomes using dexamethasone / antibiotic adjuvant therapy following hysterosalpingography in infertile females: A randomised trial. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247775 ↩︎
  13. Zhang T, et al. (2017). Successful treatment with intrauterine delivery of dexamethasone for repeated implantation failure. https://onlinelibrary.wiley.com/doi/10.1111/aji.12766 ↩︎
  14. Espino J, et al. (2019). Impact of Melatonin Supplementation in Women with Unexplained Infertility Undergoing Fertility Treatment. https://www.mdpi.com/2076-3921/8/9/338 ↩︎
  15. Hunault C C, et al. (2004). Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. https://academic.oup.com/humrep/article/19/9/2019/782277 ↩︎
  16. Van Eekelen R, et al. (2017). Natural conception: repeated predictions over time. https://academic.oup.com/humrep/article/32/2/346/2713082 ↩︎
  17. Kersten F A, et al. (2015). Overtreatment in couples with unexplained infertility. https://academic.oup.com/humrep/article/30/1/71/682326 ↩︎
  18. Gelbaya T A, et al. (2014). Definition and Epidemiology of Unexplained Infertility. https://journals.lww.com/obgynsurvey/abstract/2014/02000/definition_and_epidemiology_of_unexplained.17.aspx ↩︎
  19. Hu H, et al. (2022). Lipiodol flushing under ultrasound guidance at time of hystero-salpingo contrast sonography (HyCoSy): A retrospective observational study. https://obgyn.onlinelibrary.wiley.com/doi/10.1111/ajo.13558 ↩︎
  20. Dreyer K, et al. (2017). Oil-Based or Water-Based Contrast for Hysterosalpingography in Infertile Women. https://www.nejm.org/doi/10.1056/NEJMoa1612337 ↩︎
  21. Mathews D M, et al. (2021). Iodine and fertility: do we know enough? https://academic.oup.com/humrep/article/36/2/265/6025913 ↩︎
  22. Li R, et al. (2022). Effects of hysterosalpingo-contrast sonography examination on endometrial receptivity among women with unexplained infertility. https://link.springer.com/article/10.1007/s00404-022-06620-2 ↩︎
  23. Lo G, et al. (2024). Ultrasound-guided Lipiodol® hysterosalpingography: A prospective study on pregnancy and complication rates. https://obgyn.onlinelibrary.wiley.com/doi/10.1111/ajo.13794 ↩︎
  24. Mathews D M, et al. (2022). The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography. https://academic.oup.com/jcem/article/107/12/3252/6704756 ↩︎
  25. Marin L, et al. (2023). Letter to the Editor From Marin et al: “The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography”. https://academic.oup.com/jcem/article-abstract/108/9/e899/7084112 ↩︎
  26. Markram J, et al. (2022). Sperm-friendly lubricant: Fact or fiction. https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.14136 ↩︎
  27. Soriano M J, et al. (2021). The Use of Vaginal Lubricants and Ultrasound Gels Can have Deleterious Effects on Sperm Function. https://journals.lww.com/jhrs/fulltext/2021/14020/the_use_of_vaginal_lubricants_and_ultrasound_gels.10.aspx ↩︎
  28. Wong T W, et al. (2022). Effect of endometrial scratching on unassisted conception for unexplained infertility: a randomized controlled trial. https://www.fertstert.org/article/S0015-0282(21)02295-0/fulltext ↩︎
  29. Wessel J A, et al. (2022). Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial. https://academic.oup.com/humrep/article/37/12/2808/6798815 ↩︎
  30. Barbonetti A, et al. (2020). Relationship between natural and intrauterine insemination-assisted live births and the degree of sperm autoimmunisation. https://academic.oup.com/humrep/article/35/6/1288/5827878 ↩︎
  31. Olatunji O and More A, (2022). A Review of the Impact of Microfluidics Technology on Sperm Selection Technique. https://www.cureus.com/articles/104256-a-review-of-the-impact-of-microfluidics-technology-on-sperm-selection-technique#!/ ↩︎
  32. Rex A S, et al. (2021). DNA Fragmentation in Human Spermatozoa and Pregnancy Rates after Intrauterine Insemination. Should the DFI Threshold Be Lowered? https://www.mdpi.com/2077-0383/10/6/1310 ↩︎
  33. O’Neill C L, et al. (2018). A treatment algorithm for couples with unexplained infertility based on sperm chromatin assessment. https://link.springer.com/article/10.1007/s10815-018-1270-x ↩︎
  34. Berteli T S, et al. (2017). Magnetic-activated cell sorting before density gradient centrifugation improves recovery of high-quality spermatozoa. https://onlinelibrary.wiley.com/doi/10.1111/andr.12372 ↩︎
  35. Duran E H, et al. (2002). Sperm DNA quality predicts intrauterine insemination outcome: a prospective cohort study. https://academic.oup.com/humrep/article/17/12/3122/569587 ↩︎
  36. Riviere E, et al. (2020). Melatonin daily oral supplementation attenuates inflammation and oxidative stress in testes of men with altered spermatogenesis of unknown aetiology. https://www.sciencedirect.com/science/article/abs/pii/S0303720720301891? ↩︎
  37. Degirmenci Y, et al. (2020). Impact of the sexual abstinence period on the production of seminal reactive oxygen species in patients undergoing intrauterine insemination: A randomized trial. https://obgyn.onlinelibrary.wiley.com/doi/10.1111/jog.14308 ↩︎
  38. Delu A, et al. (2020). Clomiphene citrate improved testosterone and sperm concentration in hypogonadal males. https://www.tandfonline.com/doi/full/10.1080/19396368.2020.1822457 ↩︎
  39. Trussell J C, et al. (2019). Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population. https://www.fertstert.org/article/S0015-0282(19)30075-5/fulltext ↩︎
  40. Ayeleke R O, et al. (2020). Intra‐uterine insemination for unexplained subfertility. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001838.pub6/full ↩︎
  41. Guzick D S, et al. (1999). Efficacy of Superovulation and Intrauterine Insemination in the Treatment of Infertility. https://www.nejm.org/doi/full/10.1056/NEJM199901213400302 ↩︎
  42. Sapet C, et al. (2020). Results of in vitro fertilization versus intrauterine insemination in patients with low anti-Müllerian hormone levels. A single-center retrospective study of 639 + 119 cycles. https://www.sciencedirect.com/science/article/abs/pii/S2468784720302257? ↩︎
  43. Siristatidis C, et al. (2020). Special characteristics, reproductive, and clinical profile of women with unexplained infertility versus other causes of infertility: a comparative study. https://link.springer.com/article/10.1007/s10815-020-01845-z ↩︎
  44. Burks H R, et al. (2024). Effect of prematurely elevated late follicular progesterone on pregnancy outcomes following ovarian stimulation-intrauterine insemination for unexplained infertility: secondary analysis of the AMIGOS trial. https://academic.oup.com/humrep/article/39/8/1684/7686293 ↩︎
  45. Radaelli M, et al. (2022). Timed intercourse in association with controlled ovarian hyperstimulation as the first-line treatment of couples with unexplained subfertility. https://pubmed.ncbi.nlm.nih.gov/35621275/ ↩︎
  46. Wessel J A, et al. (2022). Ovarian stimulation strategies for intrauterine insemination in couples with unexplained infertility: a systematic review and individual participant data meta-analysis. https://academic.oup.com/humupd/article/28/5/733/6588517 ↩︎
  47. Zolton J R, et al. (2020). Gonadotropins versus oral ovarian stimulation agents for unexplained infertility: a systematic review and meta-analysis. https://www.fertstert.org/article/S0015-0282(19)32468-9/fulltext ↩︎
  48. Danhof N A, et al. (2020). IUI for unexplained infertility—a network meta-analysis. https://academic.oup.com/humupd/article/26/1/1/5658596 ↩︎
  49. Danhof N A, et al. (2018). Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial. https://academic.oup.com/humrep/article/33/10/1866/5076921 ↩︎
  50. Diamond M P, et al. (2015). Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. https://www.nejm.org/doi/10.1056/NEJMoa1414827 ↩︎
  51. Huang S, et al. (2021). Intrauterine insemination (IUI) with or without letrozole for unexplained or mild male factor infertility: A randomized pilot study. https://www.ejog.org/article/S0301-2115(21)00252-9/abstract ↩︎
  52. Tosun S A, et al. (2021). The utility of detecting ovulation to predict success in ovulation induction and intrauterine insemination cycles — a prospective observational study. https://journals.viamedica.pl/ginekologia_polska/article/view/75334 ↩︎
  53. Kovalak E E, et al. (2022). Hormonal Changes in Clomiphene Citrate Cycles in Unexplained Infertility Can Predict Follicle Development? https://jcpsp.pk/article-detail/phormonal-changes-in-clomiphene-citrate-cycles-in-unexplained-infertility-can-predict-follicle-developmentorp ↩︎
  54. Cetin E, et al. (2021). What Is the Mechanism of Poor Endometrial Proliferation in Patients With Unexplained Infertility After Clomiphene Citrate Treatment? https://academic.oup.com/jcem/article/106/11/e4776/6311932 ↩︎
  55. Bressler L H, et al. (2021). Poor Endometrial Proliferation After Clomiphene is Associated With Altered Estrogen Action. https://academic.oup.com/jcem/article/106/9/2547/6290161 ↩︎
  56. Marin L, et al. (2021). Sildenafil Supplementation for Women Undergoing Infertility Treatments: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. https://www.mdpi.com/2077-0383/10/19/4346 ↩︎
  57. Aboelroose A A, et al. (2020). A randomized clinical trial of sildenafil plus clomiphene citrate to improve the success rate of ovulation induction in patients with unexplained infertility. https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.13159 ↩︎
  58. Firouz M, et al. (2020). Comparing the Effectiveness of Doing Intra-uterine Insemination 36 and 42 Hours after Human Chorionic Gonadotropin (HCG) Injection on Pregnancy Rate: A Randomized Clinical Trial. https://publish.kne-publishing.com/index.php/JFRH/article/view/4670 ↩︎
  59. Soliman B S, (2016). Effect of time interval between human chorionic gonadotropin injection and intrauterine insemination on pregnancy rate. https://www.sciencedirect.com/science/article/pii/S1110569016300073? ↩︎
  60. Kamel A M, et al. (2015). The effect of delaying intrauterine insemination till 48 h after hCG injection on pregnancy rate. https://www.sciencedirect.com/science/article/pii/S1110569015300121? ↩︎
  61. Weiss A, et al. (2014). A randomized trial comparing time intervals from HCG trigger to intrauterine insemination for cycles utilizing GnRH antagonists. https://www.tandfonline.com/doi/full/10.3109/19396368.2014.951457 ↩︎
  62. Song H, et al. (2022). Effect of ovulation before or after intrauterine insemination on pregnancy outcome in patients with unexplained infertility or polycystic ovarian syndrome. https://www.tandfonline.com/doi/full/10.1080/09513590.2022.2125952 ↩︎
  63. Pekcan M K, et al. (2018). Effect of time intervals from the end of sperm collection to intrauterine insemination on the pregnancy rates in controlled ovarian hyperstimulation-intrauterine insemination cycles. https://www.sciencedirect.com/science/article/pii/S2468784718301016? ↩︎
  64. Farooqui N and Bajaj B, (2022). A Randomised Comparative Study of Standard IUI (sIUI) and Fallopian Tube Sperm Perfusion (FSP) for Clinical Pregnancy. https://link.springer.com/article/10.1007/s13224-021-01583-x ↩︎
  65. Cantineau A, et al. (2013). Intrauterine insemination versus fallopian tube sperm perfusion for non‐tubal infertility. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001502.pub4/full ↩︎
  66. Ombelet W, et al. (2021). Improving IUI success by performing modified slow-release insemination and a patient-centred approach in an insemination programme with partner semen: a prospective cohort study. https://fvvo.eu/archive/volume-13/number-4/original-articles/improving-iui-success-by-performing-modified-slow-release-insemination-and-a-patient-centred-approac/ ↩︎
  67. Hansen K R, et al. (2020). Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial. https://academic.oup.com/humrep/article/35/6/1296/5840885 ↩︎
  68. Casarramona G, et al. (2022). The efficacy and safety of luteal phase support with progesterone following ovarian stimulation and intrauterine insemination: A systematic review and meta-analysis. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.960393/full ↩︎
  69. Mehrjerd A, et al. (2022). Determination of Cut Off for Endometrial Thickness in Couples with Unexplained Infertility: Trustable AI. https://ebooks.iospress.nl/doi/10.3233/SHTI220450 ↩︎
  70. Quaas A M, et al. (2021). Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes. https://www.fertstert.org/article/S0015-0282(20)30683-X/fulltext ↩︎
  71. Hansen K R, et al. (2018). Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility. https://academic.oup.com/jcem/article/103/7/2743/4995291 ↩︎
  72. Gavrizi S Z, et al. (2022). High-sensitivity C-reactive protein levels and pregnancy outcomes in women with unexplained infertility after ovarian stimulation with intrauterine insemination in a multicenter trial. https://www.fertstertreports.org/article/S2666-3341(22)00002-2/fulltext ↩︎
  73. Weghofer A, et al. (2020). Euploid miscarriage is associated with elevated serum C-reactive protein levels in infertile women: a pilot study. https://link.springer.com/article/10.1007/s00404-020-05461-1 ↩︎
  74. Rutten A, et al. (2022). Insights into ovarian response with a fixed low dose FSH stimulation in an IUI programme: the PRORAILS study. https://academic.oup.com/humrep/article/37/7/1440/6573230 ↩︎
  75. Osmanlıoğlu Ş, et al. (2022). Intrauterine insemination with ovarian stimulation is a successful step prior to assisted reproductive technology for couples with unexplained infertility. https://www.tandfonline.com/doi/full/10.1080/01443615.2021.1916805 ↩︎
  76. Cohlen B, et al. (2018). IUI: review and systematic assessment of the evidence that supports global recommendations. https://academic.oup.com/humupd/article/24/3/300/4858544 ↩︎
  77. Ombelet W, et al. (2020). Should couples with unexplained infertility have three to six cycles of intrauterine insemination with ovarian stimulation or in vitro fertilization as first-line treatment? https://www.fertstert.org/article/S0015-0282(20)32543-7/fulltext ↩︎
  78. Carosso A R, et al. (2021). Expectant Management Before In vitro Fertilization in Women Aged 39 or Above and Unexplained Infertility Does Not Decrease Live Birth Rates Compared to Immediate Treatment. https://link.springer.com/article/10.1007/s43032-021-00767-0 ↩︎
  79. Xue Y, et al. (2022). Gene mutations associated with fertilization failure after in vitro fertilization/intracytoplasmic sperm injection. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.1086883/full ↩︎
  80. Navarro B, et al. (2021). Sperm nullisomy is not associated with routine semen parameters but it negatively impacts on ICSI outcomes. https://onlinelibrary.wiley.com/doi/10.1111/and.14026 ↩︎
  81. Erdoğan K, et al. (2023). Evaluation of Dysfunctional HDL by Myeloperoxidase/Paraoxonase Ratio in Unexplained Infertility Patients Undergoing IVF/ICSI. https://www.mdpi.com/2077-0383/12/4/1506 ↩︎
  82. Şentürk R, et al. (2022). The role of oxidant status on the etiopathogenesis of unexplained infertility and intracytoplasmic sperm injection – embryo transfer success: a case-control study. https://www.tandfonline.com/doi/full/10.1080/01443615.2021.1960294 ↩︎
  83. Petousis S, et al. (2018). Unexplained infertility patients present the mostly impaired levels of progesterone receptors: Prospective observational study. https://onlinelibrary.wiley.com/doi/10.1111/aji.12828 ↩︎
  84. Mehrjerd A, et al. (2022). Determination of Cut Off for Endometrial Thickness in Couples with Unexplained Infertility: Trustable AI. https://ebooks.iospress.nl/doi/10.3233/SHTI220450 ↩︎
  85. Majeed H, et al. (2022). Comparing the ICSI outcome between different causes of subfertility and estimate the role of IL-1β in predicting ICSI outcome. https://www.jstage.jst.go.jp/article/jmi/69/3.4/69_180/_article ↩︎
  86. Liu L, et al. (2020). Association between serum homocysteine level and unexplained infertility in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI): A retrospective, hospital-based, case-control study. https://onlinelibrary.wiley.com/doi/10.1002/jcla.23167 ↩︎
  87. Olatunji O and More A, (2022). A Review of the Impact of Microfluidics Technology on Sperm Selection Technique. https://www.cureus.com/articles/104256-a-review-of-the-impact-of-microfluidics-technology-on-sperm-selection-technique#!/ ↩︎
  88. Eidizadeh A, et al. (2022). Adverse drug reactions following lymphocyte immunotherapy for the treatment of infertility: A retrospective study. https://obgyn.onlinelibrary.wiley.com/doi/10.1111/jog.15348 ↩︎
  89. Coksuer H, et al. (2019). Improved in vitro fertilization success and pregnancy outcome with autologous platelet-rich plasma treatment in unexplained infertility patients that had repeated implantation failure history. https://www.tandfonline.com/doi/full/10.1080/09513590.2019.1597344 ↩︎
  90. Paffoni A, et al. (2024). O-187 Real-word data on effectiveness of ICSI over conventional IVF according to infertility factors based on human fertilisation and embryology authority dataset. https://academic.oup.com/humrep/article/39/Supplement_1/deae108.220/7703357 ↩︎
  91. Tejera A, et al. (2021). Treatment with Calcium Ionophore Improves The Results in Patients with Previous Unsuccessful Attempts at The Fertilization: A Cohort Study. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530221/ ↩︎
  92. Gennarelli G, et al. (2019). ICSI versus Conventional IVF in Women Aged 40 Years or More and Unexplained Infertility: A Retrospective Evaluation of 685 Cycles with Propensity Score Model. https://www.mdpi.com/2077-0383/8/10/1694 ↩︎
  93. Song J, et al. (2020). ICSI Does Not Improve Live Birth Rates but Yields Higher Cancellation Rates Than Conventional IVF in Unexplained Infertility. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2020.614118/full ↩︎
  94. Izhar R, et al. (2019). Fertility outcome after saline sonography guided removal of intrauterine polyps in women with unexplained infertility. https://jultrason.pl/index.php/issues/volume-19-no-77/fertility-outcome-after-saline-sonography-guided-removal-of-intrauterine-polyps-in-women-with-unexplained-infertility?aid=715#overlay ↩︎
  95. Jee B C and Jeong H G, (2021). Management of endometrial polyps in infertile women: A mini-review. https://ecerm.org/journal/view.php?doi=10.5653/cerm.2020.04119 ↩︎
  96. Metwally M, et al. (2020). Surgical treatment of fibroids for subfertility. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003857.pub4/full ↩︎
  97. Casini M L, et al. (2006). Effects of the position of fibroids on fertility. https://www.tandfonline.com/doi/full/10.1080/09513590600604673 ↩︎
  98. Bonanni V, et al. (2022). The impact of small and asymptomatic intramural and subserosal fibroids on female fertility: a case–control study. https://academic.oup.com/hropen/article/2023/1/hoac056/6883910 ↩︎
  99. Mercorio A, et al. (2023). Myomectomy in infertile women: More harm than good? https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2023.1151901/full ↩︎
  100. Rikken J, et al. (2021). Septum resection versus expectant management in women with a septate uterus: an international multicentre open-label randomized controlled trial. https://academic.oup.com/humrep/article/36/5/1260/6208126 ↩︎
  101. Acet F, et al. (2022). Reproductive and ICSI outcomes after hysteroscopic metroplasty for T-shaped uterus, a prospective follow up study. https://www.sciencedirect.com/science/article/pii/S2468784722001349? ↩︎
  102. Mutlu A, (2022). IVF outcomes after T-shaped uterine metroplasty in patients with recurrent implantation failure. https://www.sciencedirect.com/science/article/pii/S2468784722000460? ↩︎
  103. Pabuccu R, et al. (2020). Reproductive outcomes of patients with T-Shaped and septate uterus following metroplasty: an observational study. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162664/ ↩︎

Share this post

Share on LinkedIn Share on Pinterest

fertilPEDIA

Questions or comments?